MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹273 Cr | ₹205 Cr | ₹84 Cr | ₹57 Cr | ₹24 Cr |
What is the latest Total Non-Current Liabilities ratio of MARKSANS PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹273 Cr |
| Mar2024 | ₹205 Cr |
| Mar2023 | ₹84 Cr |
| Mar2022 | ₹57 Cr |
| Mar2021 | ₹24 Cr |
How is Total Non-Current Liabilities of MARKSANS PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹273 Cr | 33.00 | |
| Mar2024 | ₹205 Cr | 143.34 | |
| Mar2023 | ₹84 Cr | 47.80 | |
| Mar2022 | ₹57 Cr | 140.72 | |
| Mar2021 | ₹24 Cr | - | |
Compare Total Non-Current Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹8,701.4 Cr | 0.4% | 5.5% | -42% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,412.0 Cr | -0.4% | 6.4% | 4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,343.0 Cr | -1.5% | -4.9% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,191.0 Cr | -0.7% | 4.8% | 16.6% | Stock Analytics | |
| CIPLA | ₹122,511.0 Cr | -0.5% | 1% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,523.0 Cr | 2.2% | 6.6% | 5.7% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 0.4% |
5.5% |
-42% |
| SENSEX | 0.7% |
0.9% |
6.1% |
You may also like the below Video Courses